Delivra Health Brands Stock Today

DHB Stock   0.19  0.01  5.00%   

Performance

Weakest

 
Weak
 
Strong

Odds Of Distress

Risky

 
High
 
Low
Delivra Health is selling for under 0.19 as of the 15th of September 2025; that is 5% down since the beginning of the trading day. The stock's lowest day price was 0.19. Delivra Health has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 17th of June 2025 and ending today, the 15th of September 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Delivra Health is entity of Canada. It is traded as Stock on V exchange. The company has 31.26 M outstanding shares of which 1.01 K shares are currently shorted by private and institutional investors with about 0.25 days to cover all short positions. More on Delivra Health Brands

Moving against Delivra Stock

  0.31BRK Berkshire Hathaway CDRPairCorr

Delivra Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Delivra Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Delivra Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO PresidentGord Davey
Thematic IdeaHealth Management (View all Themes)
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Management, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors)
Delivra Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Delivra Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Delivra Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Delivra Health's financial leverage. It provides some insight into what part of Delivra Health's total assets is financed by creditors.
Liquidity
Delivra Health cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Delivra Health Brands has accumulated 242 K in total debt. Debt can assist Delivra Health until it has trouble settling it off, either with new capital or with free cash flow. So, Delivra Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Delivra Health Brands sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Delivra to invest in growth at high rates of return. When we think about Delivra Health's use of debt, we should always consider it together with cash and equity.

Capital Expenditures

0.0
Delivra Health Brands (DHB) is traded on TSX Venture Exchange in Canada and employs 8 people. Delivra Health is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.94 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Delivra Health's market, we take the total number of its shares issued and multiply it by Delivra Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Delivra Health Brands classifies itself under Pharmaceuticals sector and is part of Health Care industry. The entity has 31.26 M outstanding shares of which 1.01 K shares are currently shorted by private and institutional investors with about 0.25 days to cover all short positions. Delivra Health generates positive cash flow from operations, but has no cash available
Check Delivra Health Probability Of Bankruptcy
Ownership Allocation
Delivra Health holds a total of 31.26 Million outstanding shares. Delivra Health Brands shows 11.43 percent of its outstanding shares held by insiders and 1.86 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Delivra Ownership Details

Delivra Health Brands Risk Profiles

Although Delivra Health's alpha and beta are two of the key measurements used to evaluate Delivra Health's performance over the market, the standard measures of volatility play an important role as well.

Delivra Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Delivra Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Insider Screener Now

   

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Module

Delivra Health Corporate Management

Elected by the shareholders, the Delivra Health's board of directors comprises two types of representatives: Delivra Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Delivra. The board's role is to monitor Delivra Health's management team and ensure that shareholders' interests are well served. Delivra Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Delivra Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ann GallerySenior CommunicationsProfile
Matthew WagarSenior InnovationProfile
Will StewartSr AffairsProfile
CPA CGAVP FinProfile

Additional Tools for Delivra Stock Analysis

When running Delivra Health's price analysis, check to measure Delivra Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Delivra Health is operating at the current time. Most of Delivra Health's value examination focuses on studying past and present price action to predict the probability of Delivra Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Delivra Health's price. Additionally, you may evaluate how the addition of Delivra Health to your portfolios can decrease your overall portfolio volatility.